Immix Biopharma, Inc. IMMX Other Current Liabilities
Other Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s other current liabilities?
- Immix Biopharma, Inc. (IMMX) reported other current liabilities of $432.21K in Q1 2026.
- How has Immix Biopharma, Inc.'s other current liabilities changed year-over-year?
- Immix Biopharma, Inc.'s other current liabilities increased by 67.1% year-over-year, from $258.72K to $432.21K.